If you need more lookups,
subscriptions start at $34 USD/month.
Danielle Talbot Location
United States
Danielle Talbot Work
2025 -now Director, Clinical Biomarkers @
2024 -2025 Director, Translational Medicine @
2022 -2024 Principal Scientist, Translational Research Lead, Multiple Myeloma @
2021 -2024 Senior Medical Science Liaison-Oncology @
2020 -2021 Lead Investigator Immuno-oncology @
2017 -2020 Senior Scientist and Scientist II- Immuno-Oncology Discovery @
2015 -2017 Postdoctoral Fellow @
Danielle Talbot Education
Washington University in St. Louis
Post-Doc (Immuno-oncology (Schreiber lab))
2015-2017
Arizona State University
Doctor of Philosophy (PhD) (Immunology)
2010-2015
The University of Texas at Austin
Bachelor of Science (B.S.) (Neurobiology)
2005-2009
Danielle Talbot Summary
Danielle Talbot, based in United States, is currently a Director, Clinical Biomarkers at LTZ Therapeutics. Danielle Talbot brings experience from previous roles at Dragonfly Therapeutics, Inc., Johnson & Johnson Innovative Medicine and Inimmune. Danielle Talbot holds a 2015 - 2017 Post-Doc in Immuno-oncology (Schreiber lab) @ Washington University in St. Louis. Danielle Talbot has 1 emails on RocketReach.
Looking for a different Danielle Talbot?
Find contact details for 700 million professionals.